Issue 7 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

28

No.

7

February 15, 2002Feb 15, 2002

Free

DOWNLOAD THE PDF

Expert Review Of ImClone Protocol Concludes C225 Approval Unlikely.

Retrospective Data Clean-Up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”.

ImClone Protocol Generates More Questions Than Answers.

Phase III Trial Would Give Clearer Picture Of C225 Role.

Thomas Jordan To Help ASCO Enhance International Relations, Retires From BMS.

Levine Leaves Presidency Of Rockefeller University.

Recent Issues

Volume 52 | Issue 09 - March 06, 2026

Volume 52 | Issue 08 - February 27, 2026

Volume 52 | Issue 07 - February 20, 2026

Volume 52 | Issue 06 - February 13, 2026

Volume 52 | Issue 05 - February 06, 2026

Volume 52 | Issue 04 - January 30, 2026